Tongjitang Chinese Medicines Co.

Shenzhen, Guangdong Province, China • 86-75526891550 •

Exchange and Ticker: NYSE: TCM

Filing Range: 8.35M shares @ $15.00 to $17.00

Offering Price: $10.00

Close on First Day: $9.75

Offering Size: $98.70M

Shares Outstanding: 9,865,000

Underwriters: Merrill Lynch/ UBS Investment Bank

Co-managers: CIBC World Markets Inc.

Company Counsel: Latham & Watkins

Manager Counsel: Cleary Gottlieb Steen & Hamilton

Auditor: Deloitte Touche Tohmatsu

Market Capitalization on 3/31/07: $99.24M

Close price at current month end: $10.06


Develops, manufactures traditional Chinese medicine. Company’s flagship product, Xianling Gubao, is a traditional Chinese medicine for the treatment of osteoporosis in China. Tongjitang’s product development pipeline includes potential expanded uses of its existing products for additional medical indications and a number of new product candidates that are intended to address significant medical needs in China, primarily in the therapeutic areas of women’s health, mental health and dermatology. Competitors include Guizhou Fuhua Pharmaceutical Co. Ltd. and Beijing Qihuang Pharmaceutical Co. Ltd.


Merrill Lynch Venture Capital

Source: Thomson Financial